Literature DB >> 26041384

International prevalence of the use of peripheral intravenous catheters.

Evan Alexandrou1,2,3, Gillian Ray-Barruel3,4, Peter J Carr3,4,5, Steven Frost1,2, Sheila Inwood6,7, Niall Higgins3, Frances Lin3, Laura Alberto8, Leonard Mermel9, Claire M Rickard3,4.   

Abstract

Over a billion peripheral intravenous catheters (PIVCs) are inserted each year in hospitalized patients worldwide. However, international data on prevalence and management of these devices are lacking. The study assessed the prevalence of PIVCs and their management practices across different regions of the world. This global audit involved 14 hospitals across 13 countries, with 479 patients screened for the presence of a PIVC. We found 59% of patients had at least 1 PIVC in place, and 16% had other types of vascular devices. We also found that overall, 25% of patients had no vascular device in place. The majority of PIVCs were inserted by nursing staff or a specialist team. The prevalence of idle PIVCs in place with no fluid or medication orders was 16%, and 12% of PIVCs had at least 1 symptom of phlebitis.
© 2015 Society of Hospital Medicine.

Entities:  

Mesh:

Year:  2015        PMID: 26041384     DOI: 10.1002/jhm.2389

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  26 in total

1.  Adsorption and Leachable Contamination of Flucloxacillin, Cyclosporin and Amiodarone Following Delivery Through an Intravenous Administration Set.

Authors:  Zachary Woodward; Peter Brooks; Bernadette Morris-Smith; Marianne Wallis; Steven M Ogbourne
Journal:  Pharm Res       Date:  2018-04-19       Impact factor: 4.200

2.  Compare the efficacy of recommended peripheral intravascular cannula insertion practices with a standard protocol: A randomized control trial.

Authors:  Ashutosh Gupta; Rajeev Nair; Shalendra Singh; Hitesh Khanna; Amresh Bal; Seema Patrikar
Journal:  Med J Armed Forces India       Date:  2022-04-02

3.  Design and Evaluation of a Handheld Robotic Device for Peripheral Catheterization.

Authors:  Josh Leipheimer; Max Balter; Alvin Chen; Martin Yarmush
Journal:  J Med Device       Date:  2022-03-02       Impact factor: 0.743

4.  First-in-human evaluation of a hand-held automated venipuncture device for rapid venous blood draws.

Authors:  Josh M Leipheimer; Max L Balter; Alvin I Chen; Enrique J Pantin; Alexander E Davidovich; Kristen S Labazzo; Martin L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2020-01-22

5.  Peripherally Inserted Central Catheters and Hemodialysis Outcomes.

Authors:  Rita L McGill; Robin Ruthazer; Klemens B Meyer; Dana C Miskulin; Daniel E Weiner
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

Review 6.  Infection risks associated with peripheral vascular catheters.

Authors:  Li Zhang; Siyu Cao; Nicole Marsh; Gillian Ray-Barruel; Julie Flynn; Emily Larsen; Claire M Rickard
Journal:  J Infect Prev       Date:  2016-07-06

7.  Risk factors for peripheral venous catheter failure: A prospective cohort study of 5345 patients.

Authors:  Ya-Mei Chen; Xiao-Wen Fan; Ming-Hong Liu; Jie Wang; Yi-Qun Yang; Yu-Fang Su
Journal:  J Vasc Access       Date:  2021-05-13       Impact factor: 2.326

8.  Development of a clinical prediction rule to improve peripheral intravenous cannulae first attempt success in the emergency department and reduce post insertion failure rates: the Vascular Access Decisions in the Emergency Room (VADER) study protocol.

Authors:  Peter J Carr; James C R Rippey; Marie L Cooke; Chrianna Bharat; Kevin Murray; Niall S Higgins; Aileen Foale; Claire M Rickard
Journal:  BMJ Open       Date:  2016-02-11       Impact factor: 2.692

9.  A clinical pathway for the management of difficult venous access.

Authors:  Vanno Sou; Craig McManus; Nicholas Mifflin; Steven A Frost; Julie Ale; Evan Alexandrou
Journal:  BMC Nurs       Date:  2017-11-17

10.  Multisensory System for the Detection and Localization of Peripheral Subcutaneous Veins.

Authors:  Roemi Fernández; Manuel Armada
Journal:  Sensors (Basel)       Date:  2017-04-19       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.